Glucagon-like peptide-1 receptor agonists linked to a reduced risk of developing asthma among patients with type 2 diabetes
Background: Studies have suggested that glucagon-like peptide-1 receptor agonists (GLP-1 RAs) may modulate asthma-related immune pathways, but evidence directly linking the use of GLP-1 RAs to asthma onset remains limited. Objectives: We aimed to evaluate whether the use of GLP-1 RAs in patients wit...
Kaydedildi:
| Asıl Yazarlar: | , , , , , , , , , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
SAGE Publishing
2025-12-01
|
| Seri Bilgileri: | Therapeutic Advances in Endocrinology and Metabolism |
| Online Erişim: | https://doi.org/10.1177/20420188251400536 |
| Etiketler: |
Etiket eklenmemiş, İlk siz ekleyin!
|